Educational aims
Up to a third of people that have had COVID-19 experience lingering symptoms or develop chronic health problems (https://pubmed.ncbi.nlm.nih.gov/34223884/).
This session will share perspectives from around the world, including experts from Europe, North America and Southeast Asia. The experts will share insights on the current research, clinical observations, and future perspectives on long COVID.
This webinar is organised as a follow-up to the April 2021 EU-funded COVID-19: State of the Art – DRAGON IMI project, presenting fresh updates in COVID research.
Format
1-hour panel discussion (brief opening addresses by each speaker, followed by a panel discussion with Q&A from the audience)
Topics
- Long COVID
- Recovery
- Treatment
- Long term outlook
CME credit
An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.
What is a webinar?
This webinar comprises a 45-minute panel discussion followed by a 15-minute question-and-answer session.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
Login guidelines
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
- Check Central European Time.
- To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Funded by
The DRAGON project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005122. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. More information is available at: https://www.imi.europa.eu/.
Connect on Linkedin
